I understand some strides in leukemia and glioblastoma research have been made:
1) A science team at Stanford did when actually trying to keep B-cell leukemia cells alive post extraction, inadvertently matured the cells turning them into immune cells to actually assist in destroying the remaining cancer cells.
2) PVS-RIPO is a genetically engineered poliovirus that is being investigated as a new anti-cancer agent at the Preston Robert Tisch Brain Tumor Center at Duke. (a piece of genetic code of a cold-causing rhinovirus was spliced into the poliovirus genome). PVS-RIPO naturally infects almost all cancer cells, because the receptor for poliovirus (which is used for cell entry) is abnormally present on most tumor cells. PVS-RIPO kills cancer cells, but not normal cells, because its ability to grow (and kill) depends on biochemical abnormalities only present in cancer cells.
Have you encountered any trials of these items as of yet?
ikagadeska5 karma
I understand some strides in leukemia and glioblastoma research have been made:
1) A science team at Stanford did when actually trying to keep B-cell leukemia cells alive post extraction, inadvertently matured the cells turning them into immune cells to actually assist in destroying the remaining cancer cells.
2) PVS-RIPO is a genetically engineered poliovirus that is being investigated as a new anti-cancer agent at the Preston Robert Tisch Brain Tumor Center at Duke. (a piece of genetic code of a cold-causing rhinovirus was spliced into the poliovirus genome). PVS-RIPO naturally infects almost all cancer cells, because the receptor for poliovirus (which is used for cell entry) is abnormally present on most tumor cells. PVS-RIPO kills cancer cells, but not normal cells, because its ability to grow (and kill) depends on biochemical abnormalities only present in cancer cells.
Have you encountered any trials of these items as of yet?
View HistoryShare Link